Correspondingly, VEGF-C induction that enhances the lymphatic density and function has been shown to have therapeutic effects against IBD by clearing inflammatory cells and bacterial antigens and by modulating the macrophage activities [104]. Here, VEGFC is linked to inflammatory bowel disease.